News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hereditary Antithrombin Deficiency and rEVO Biologics’ ATryn to Appear on January 28th TV segment on Lifetime Morning Show, The Balancing Act™


1/24/2013 9:34:41 AM

FRAMINGHAM, Mass.--(BUSINESS WIRE)--rEVO Biologics announced today that hereditary antithrombin (AT) deficiency, and the use of the company’s lead product ATryn antithrombin (Recombinant), will be the focus of a TV segment on Behind the Mystery: Rare and Genetic Diseases, the ground breaking series on The Balancing Act™, America’s premier morning show that airs weekday mornings on Lifetime Television.

Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES